Arcus Biosciences (RCUS) Other Non-Current Assets (2017 - 2026)
Arcus Biosciences (RCUS) posted Other Non-Current Assets of $59 million for Q2 2026, down 14.5% from $69 million a year earlier and down 3.3% from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Other Non-Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Arcus Biosciences' Other Non-Current Assets came in at $63 million, down 13.7% from FY2024.
- Annual Other Non-Current Assets has declined for four consecutive years, though with a five-year compound annual growth rate of 58.8% (FY2020 to FY2025).
- In prior years, Arcus Biosciences' Other Non-Current Assets was $73 million in FY2024 (-31.1%), $106 million in FY2023 (-7.0%), $114 million in FY2022 (-1.7%) and $116 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Other Non-Current Assets since Q3 2022.
- On a year-over-year basis, Other Non-Current Assets has declined in each of the last 11 quarters, with an average decline of 16.8% over the last eight quarters.
- The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q2 2023, with growth of 935.8%; the weakest was Q2 2024, with a decline of 31.2%.
- According to Business Quant data, Other Non-Current Assets for the three prior quarters was $61 million (Q1 2026), $63 million (Q4 2025) and $65 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Arcus Biosciences | 3.28 Bn | -53.05 Mn | - | 59.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.00 Mn |
| Mar 31, 2026 | 61.00 Mn |
| Dec 31, 2025 | 63.00 Mn |
| Sep 30, 2025 | 65.00 Mn |
| Jun 30, 2025 | 69.00 Mn |
| Mar 31, 2025 | 71.00 Mn |
| Dec 31, 2024 | 73.00 Mn |
| Sep 30, 2024 | 75.00 Mn |
| Jun 30, 2024 | 75.00 Mn |
| Mar 31, 2024 | 78.00 Mn |
| Dec 31, 2023 | 106.00 Mn |
| Sep 30, 2023 | 108.00 Mn |
| Jun 30, 2023 | 109.00 Mn |
| Mar 31, 2023 | 112.00 Mn |
| Dec 31, 2022 | 114.00 Mn |
| Sep 30, 2022 | 10.60 Mn |
| Jun 30, 2022 | 10.52 Mn |
| Mar 31, 2022 | 10.89 Mn |
| Dec 31, 2021 | 116.00 Mn |
| Sep 30, 2021 | 3.01 Mn |
API Access
Arcus Biosciences Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();